Autologous Tumor Infiltrating Lymphocytes LM103
autologous tumor infiltrating lymphocytes lm103
"A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs LM103 specifically recognize and kill the patient's tumor cells."